Health-related quality-of-life assessment of patients with solid tumors on immuno-oncology therapies.

Voon, Pei Jye; Cella, David; Hansen, Aaron R

Voon, Pei Jye; Cella, David; Hansen, Aaron R.

Affiliation

Voon PJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Cella D; Department of Medicine, Division of Medical Oncology and Hematology, University of Toronto, Toronto, Ontario, Canada.
Hansen AR; Department of Medical Social Sciences, Northwestern University, Chicago, Illinois.

Cancer ; 127(9): 1360-1368, 2021 05 01.

Article in En | MEDLINE | ID: mdl-33662145

Subject(s)

Antineoplastic Agents, Immunological/adverse effects; Immunotherapy/adverse effects; Neoplasms/therapy; Patient Reported Outcome Measures; Quality of Life; Antineoplastic Agents, Immunological/economics; Clinical Trials as Topic; Drug Costs; Humans; Patient Outcome Assessment; Reproducibility of Results; Risk Assessment

Key words

Functional Assessment of Cancer Therapy-Immune Checkpoint Modulators (FACT-ICM); Functional Assessment of Cancer Therapy-Immunotherapy (FACT-Immunotherapy); health-related quality of life (HRQOL); immune-related adverse events; immuno-oncology therapies; patient-reported outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Patient Reported Outcome Measures / Antineoplastic Agents, Immunological / Immunotherapy / Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Year: 2021 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google